Others may require dose escalation or maximal doses to experience an effect, and studies show that 20% of individuals are complete non-responders, meaning they do not experience any weight reduction despite maximal doses of the drug. With this in mind, the average experience with GLP-1s includes a gradual onset of benefits, says Dr
Peptides 31 , 950955 (2010) Haque, T
That caloric deficit drives weight loss, which is the entire point
GLP-1 therapies, which effectively regulate blood glucose levels and support weight loss, have gained widespread acceptance among healthcare providers (HCPs) and patients
However, more widespread use of GLP-1RAs is likely to have broader impacts on eating and fitness habits, population health and consumer behavior
Unlike telogen effluvium, androgenic alopecia does not fully self-resolve and may benefit from specific treatments like minoxidil or finasteride